西氏医药服务

252.94
开盘价
250.13
市值
18.22B+
最高价
258.24
最低价
249.59
收盘价
NaN
成交量
214.58K+
市盈率
37.22
股息率
0.34%

西氏医药服务简介

西氏医药服务公司致力于生产和销售药品,生物制剂,疫苗和消费保健产品。公司通过以下业务部门运营:专有产品和合同制造产品。专有产品业务部门为生物,非专利和制药客户提供专有的包装,密闭和药物输送产品,以及分析实验室服务。合同制造产品业务部门是一项完全集成的业务,主要致力于复杂设备的设计,制造和自动化组装,主要面向制药,诊断和医疗设备客户。该公司由Herman O. West于1923年7月27日成立,总部位于宾夕法尼亚州埃克斯顿。

如何购买 西氏医药服务 (WST)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 WST

购买 WST

通过 RockFlow App 或网页端搜索 WST,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.